Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Auto-antibody Dosage From Blood Spots for Diagnosis of Type 1 Diabetes and Celiace Disease

NCT06849622 is registered in ClinicalTrials.gov with Meyer Children's Hospital IRCCS as lead sponsor.

NCT NCT06849622
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06849622 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Auto-antibody Dosage From Blood Spots for Diagnosis of Type 1 Diabetes and Celiace Disease
Lead sponsor
Meyer Children's Hospital IRCCS
Phase
Not applicable
Overall status
Recruiting
Start date
November 4, 2024
Completion date
March 30, 2026
Enrollment
1,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

celiac disease in children, diabetes mellitus, type i, screening